Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
27%(3 trials)

Phase Distribution

Ph not_applicable
4
31%
Ph phase_3
2
15%
Ph phase_1
3
23%
Ph phase_2
2
15%
Ph phase_4
2
15%

Phase Distribution

3

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
3(23.1%)
Phase 2Efficacy & side effects
2(15.4%)
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
2(15.4%)
N/ANon-phased studies
4(30.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(11)
Other(1)

Detailed Status

Completed11
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (23.1%)
Phase 22 (15.4%)
Phase 32 (15.4%)
Phase 42 (15.4%)
N/A4 (30.8%)

Trials by Status

not_yet_recruiting18%
unknown18%
completed1185%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13